Results 141 to 150 of about 1,186,422 (232)

Comparaison entre scanner et morphoTEP dans l'évaluation du stade TN d'une lésion pulmonaire suspecte

open access: yes, 2005
BUT: Comparer les performances du scanner et du morphoTEP dans la caractérisation et l'évaluation du stade TNM d'une lésion pulmonaire suspecte. MATERIEL ET METHODE: 43 patients porteurs de nodule ou masse pulmonaire et ayant bénéficié à la fois d'un ...
CIPRIAN-CORBY, Sandrine, REGENT, Denis
core  

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Region Specific miRNA–mRNA Networks in Gray and White Matter Lesions of Progressive Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a neurodegenerative demyelinating disease of the central nervous system. This study aimed to identify micro‐RNA (miRNA)–mRNA regulatory networks underlying region‐specific molecular mechanisms in white matter and gray matter lesions in progressive MS.
Adya Sapra   +5 more
wiley   +1 more source

Comparative Analysis of Choroid Plexus Volume Between MOG Antibody Associated Disease and Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Choroid plexus volume (CPV) has been proposed as a neuro‐immunological marker of multiple sclerosis (MS), but its relevance in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) remains uncertain. We analyzed CPV in 43 individuals with MOGAD, 48 with MS, and 44 healthy controls using a Bayesian Gaussian mixture modeling ...
Jae‐Won Hyun   +4 more
wiley   +1 more source

Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions. [PDF]

open access: yesGlia
Reukauf L   +9 more
europepmc   +1 more source

“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez   +29 more
wiley   +1 more source

Après lésion droite: somatoparaphrénie

open access: yes
Ce travail est une revue des 56 patients publiés dans la littérature scientifique, présentant, à la suite d’une lésion cérébrale, un délire affectant la partie controlésionnelle du corps ou somatoparaphrénie.
Ronchi, Roberta, Vallar, Giuseppe
core  

Influence of dominant sequence artifacts on generative AI for virtual contrast-enhancement in breast MRI. [PDF]

open access: yesBMC Med Imaging
Brock L   +14 more
europepmc   +1 more source

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Home - About - Disclaimer - Privacy